Assetmark, Inc Halozyme Therapeutics, Inc. Transaction History

Assetmark, Inc

$41.6 Billion
Q2 2025

A detailed history of Assetmark, Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 121,538 shares of HALO stock, worth $8.27 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

121,538

Previous 105,971 14.69%

Holding current value

$8.27 Million

Previous $6.76 Million 6.51%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$47.91 - $70.14 $745,814 - $1.09 Million	15,567 Added 14.69%	121,538 $6.32 Million
Q1 2025 May 06, 2025	BUY	$47.74 - $65.16 $152,768 - $208,512	3,200 Added 3.11%	105,971 $6.76 Million
Q4 2024 Feb 06, 2025	BUY	$42.57 - $61.09 $409,182 - $587,197	9,612 Added 10.32%	102,771 $4.91 Million
Q3 2024 Nov 01, 2024	BUY	$51.3 - $64.42 $430,150 - $540,161	8,385 Added 9.89%	93,159 $5.33 Million
Q2 2024 Aug 13, 2024	SELL	$37.81 - $52.4 $876,208 - $1.21 Million	-23,174 Reduced 21.47%	84,774 $4.44 Million
Q1 2024 May 06, 2024	BUY	$33.68 - $41.95 $92,822 - $115,614	2,756 Added 2.62%	107,948 $4.39 Million
Q4 2023 Feb 09, 2024	BUY	$33.32 - $42.1 $1.46 Million - $1.84 Million	43,706 Added 71.08%	105,192 $3.89 Million
Q3 2023 Oct 27, 2023	SELL	$36.46 - $44.03 $600,459 - $725,130	-16,469 Reduced 21.13%	61,486 $2.35 Million
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $1.22 Million - $1.56 Million	40,263 Added 106.82%	77,955 $2.81 Million
Q1 2023 May 05, 2023	BUY	$32.86 - $55.7 $274,906 - $465,986	8,366 Added 28.53%	37,692 $1.44 Million
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $155,272 - $230,389	3,876 Added 15.23%	29,326 $1.67 Million
Q3 2022 Nov 01, 2022	BUY	$38.53 - $51.78 $896,593 - $1.2 Million	23,270 Added 1067.43%	25,450 $1.01 Million
Q2 2022 Aug 03, 2022	BUY	$37.35 - $48.3 $31,187 - $40,330	835 Added 62.08%	2,180 $96,000
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $1,950 - $2,504	-61 Reduced 4.34%	1,345 $54,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $1,622 - $2,078	51 Added 3.76%	1,406 $57,000
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $4,616 - $5,570	120 Added 9.72%	1,355 $55,000
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $12,050 - $15,692	305 Added 32.8%	1,235 $51,000
Q4 2020 Feb 10, 2021	BUY	$25.81 - $43.62 $23,616 - $39,912	915 Added 6100.0%	930 $40,000
Q4 2015 Sep 15, 2017	BUY	N/A	15	15 $0

Others Institutions Holding HALO

# of Institutions

635

Shares Held

128M

Call Options Held

408K

Put Options Held

384K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.48B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account